Why IMU is a multi multi bagger, page-20459

@Footmax

All good. But just to correct a couple of points in your post:

The fall from around 60 cents coincided with the fall in the share markets (mainly) with the arrival of COVID.

Not true. When covid hit, IMU fell from around 3c to 1.5c (and this was after the 6c capital raise). The rise from 11c to over 60c happened after covid had been around for a year. The rise was based on interim HER-Vaxx results and the spruiking of Leslie and Paul about its attractiveness to BP. The fall from 60c occurred after we had a vaccine for covid.

The fall in the sharemarket did have an impact on many companies, but the good ones have recovered. I actually posted the chart below on the CHM board to highlight the difference between biotechs headed by talented, reasonably-paid executives vs a Hopper company. As you can see, the biotech (CU6, in orange) which is also at Phase 2 with oncology treatments, floated right into the sharemarket downturn, but has since recovered and is at all time highs. Even accepting a degree of FOMO associated with IMU getting to 60c - shall we say it should only have gotten to 30c? - IMU has performed abysmally.


Yes, the CR's were a big factor as was the constant sell down by institutional groups who arrived when IMU entered the ASX200. Not sure that the BOD had much to do with the drop in SP (other than the CR's).

That's a big "other than", especially since the institutions that kept selling down discounted shares were introduced by the BoD (well, Paul).


Agree, we all want IMU to excel, I just can't see it happening with the current management team, hence my posts.

Peace out.